| Literature DB >> 28501253 |
Leandro Feo1, Michael Polcino2, Garrett M Nash3.
Abstract
Management of metastatic colorectal cancer requires accurate staging and multidisciplinary evaluation, leading to a consensus treatment plan with the ultimate goal of increasing survival and improving the quality of life, while taking into consideration the patient's performance status, disease burden, and goals of care. Since the introduction of multidrug chemotherapeutic regimens, survival of patients with metastatic colorectal cancer has improved. Many patients with unresectable disease are undergoing surgery for asymptomatic primary tumors despite evidence that it is usually a futile intervention. Palliative measures for local control of the primary tumor include colonic stents, laser therapy, and fulguration.Entities:
Keywords: Metastatic colorectal cancer; Palliative treatment; Primary tumor resection; Survival
Mesh:
Year: 2017 PMID: 28501253 PMCID: PMC5590838 DOI: 10.1016/j.suc.2017.01.012
Source DB: PubMed Journal: Surg Clin North Am ISSN: 0039-6109 Impact factor: 2.741